Baxter
FDA clears Baxter’s new Actifuse Flow bone graft substitute
The US Food and Drug Administration (FDA) has cleared surgical products maker Baxter International’s new synthetic bone graft substitute Actifuse…
Baxter receives CE-Mark for Evo IQ Infusion System
Medical equipment developer Baxter has obtained the European CE-Mark for its new Evo IQ Infusion System designed to minimise the…
